Medicare to expand coverage for a new class of costly Alzheimer’s drugs
Washington Post
The first drug potentially covered by the expanded plan, Leqembi, could be granted full approval from the Food and Drug Administration as soon as this summer.
https://www.washingtonpost.com/business/2023/06/01/alzheimers-drugs-medicare-coverage/